The mixed lineage leukemia (MLL) fusion-associated gene AF4 promotes CD133 transcription

Cancer Res. 2012 Apr 15;72(8):1929-34. doi: 10.1158/0008-5472.CAN-11-3589. Epub 2012 Feb 14.

Abstract

The AC133 epitope has been used as a marker for both normal and cancer stem cells from multiple tissue lineages. To identify transcription factors that regulate CD133 expression, we conducted parallel large-scale RNA interference screens in Caco-2 cancer cells that endogenously express CD133 and in engineered HEK293 cells that express CD133 from a heterologous promoter. The transcription factor AF4 was identified following a comparative analysis between the two screens. We then showed that AF4 is a promoter of CD133 transcription in multiple cancer cell lines. Knockdown of AF4 resulted in a dramatic reduction in CD133 transcript levels. Importantly, a subset of pediatric acute lymphoblastic leukemias (ALL) harbor a fusion oncogene results from a chromosomal translocation that juxtaposes the mixed-lineage leukemia (MLL) gene and the AF4 gene. An investigation of the functional role of CD133 in the MLL-AF4-dependent ALL cells revealed that CD133 was required for leukemia cell survival. Together, our findings show AF4-dependent regulation of CD133 expression, which is required for the growth of ALL cells. CD133 may therefore represent a therapeutic target in a subset of cancers.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • AC133 Antigen
  • Antigens, CD / biosynthesis
  • Antigens, CD / genetics*
  • Blotting, Western
  • Caco-2 Cells
  • Chromatin Immunoprecipitation
  • DNA-Binding Proteins / genetics*
  • DNA-Binding Proteins / metabolism
  • Flow Cytometry
  • Gene Expression Regulation, Neoplastic / genetics*
  • Glycoproteins / biosynthesis
  • Glycoproteins / genetics*
  • Histone-Lysine N-Methyltransferase
  • Humans
  • Leukemia, Biphenotypic, Acute / genetics*
  • Leukemia, Biphenotypic, Acute / metabolism
  • Leukemia, Biphenotypic, Acute / pathology
  • Myeloid-Lymphoid Leukemia Protein / genetics*
  • Myeloid-Lymphoid Leukemia Protein / metabolism
  • Neoplastic Stem Cells / metabolism
  • Nuclear Proteins / genetics*
  • Nuclear Proteins / metabolism
  • Oncogene Proteins, Fusion / genetics
  • Oncogene Proteins, Fusion / metabolism
  • Peptides / genetics*
  • RNA Interference
  • Transcription, Genetic
  • Transcriptional Elongation Factors

Substances

  • AC133 Antigen
  • Antigens, CD
  • DNA-Binding Proteins
  • Glycoproteins
  • KMT2A protein, human
  • Nuclear Proteins
  • Oncogene Proteins, Fusion
  • PROM1 protein, human
  • Peptides
  • Transcriptional Elongation Factors
  • Myeloid-Lymphoid Leukemia Protein
  • AFF1 protein, human
  • Histone-Lysine N-Methyltransferase